Acute Ischemic Stroke Clinical Trials in Chicago, Illinois

5 studies are recruiting for acute ischemic stroke in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

   SELECT LATE trial aims to evaluate if addition of endovascular thrombectomy to medical management in patients presenting with acute ischemic stroke and a proximal large vessel occlusion in the anterior circulation between 24 and 72 hours of stroke onset results in achieving better functional outcom…

   Stage

   Not phased

   Ages

   18 to 85

   Site

   University of Chicago, Chicago, Illinois

   Locations

   6 in total

   Run by

   Amrou Sarraj

   See if you can join NCT07115940 on ClinicalTrials.gov

2. The Pivotal Study of RapidPulseTM Aspiration System

   The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in t…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Rush University Medical Center, Chicago, Illinois

   Locations

   30 in total

   Run by

   RapidPulse, Inc

   See if you can join NCT06029491 on ClinicalTrials.gov

3. Blood Pressure Variability and Ischemic Stroke Outcome

   The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are: 1. To determine the association of BPV with functional/cognitive outcome after ischemic stroke. 2. To determin…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Chicago Medical Center, Chicago, Illinois

   Locations

   3 in total

   Run by

   Yale University

   See if you can join NCT05756257 on ClinicalTrials.gov

4. Optimizing Reperfusion to Improve Outcomes and Neurologic Function

   The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question the study aims to answer are: 1. JX10 improves functional outcomes as measured by the modified Rankin …

   Stage

   Phase 2

   Ages

   18 to 90

   Site

   Corxel Investigational Site, Chicago, Illinois

   Locations

   83 in total

   Run by

   Corxel Pharmaceuticals

   See if you can join NCT06990867 on ClinicalTrials.gov

5. Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

   The primary objective is to establish the efficacy of intra-arterial (IA) mechanical thrombectomy (MT) with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patients with acute ischemic stroke (AIS) from intracranial vessel occlusion (IVO) in the anterior circul…

   Stage

   Phase 3

   Ages

   18 to 79

   Site

   Ascension/Alexian Brothers Health System, Chicago, Illinois

   Locations

   51 in total

   Run by

   Mercy Health Ohio

   See if you can join NCT05611242 on ClinicalTrials.gov